Leveraging Registries: A Next Step In National Post-Market Plan
This article was originally published in The Gray Sheet
Executive Summary
FDA is making a major push as part of its new post-market surveillance strategy to make better use of existing national patient registries, while avoiding imposition of additional mandatory device registries.
You may also be interested in...
Pressure On CMS To Add UDI To Claims Forms Continues
The West Health Institute has joined a group of stakeholders calling for incorporating Unique Device Identifier codes in reimbursement claims forms to improve postmarket surveillance. But hospital and physician groups continue to push against the notion, stating it would create unnecessary burdens.
FDA Post-Market Plan Gains Support, But Many Details Still Lacking
A diverse set of stakeholders backed FDA’s new proposed national post-market surveillance plan during a series of public meetings last week, but participants warned “the devil is in the details.”
FDA Post-Market Plan Gains Support, But Many Details Still Lacking
A diverse set of stakeholders backed FDA’s new proposed national post-market surveillance plan during a series of public meetings last week, but participants warned “the devil is in the details.”